SGLT2 Inhibitors Safe for HF in Congenital Heart Disease : c

SGLT2 inhibitors not only were safe in adult patients with congenital heart disease who develop heart failure but also were associated with reduced hospitalizations.

Related Keywords

Minnesota , United States , Netherlands , University Medical Center , Anastasiad Egorova , Lukej Burchill , , Journal Of The American College Cardiology , European Society Of Cardiology , Department Of Cardiovascular Medicine , Leiden University Medical Center , American College , European Society , Cardiovascular Medicine , Mayo Clinic , Heart Failure , Sglt2 Inhibitors , Odium Glucose Transporter 2 Inhibitors , Odium Glucose Co Transporter 2 Inhibitors , Sodium Glucose Cotransporter 2 Inhibitors , Diabetes Mellitus Type 2 , Iabetes Mellitus Type Ii , Type 2 Diabetes , Ype 2 Dm , T2dm , 2d , Congenital Heart Disease , Heart , Arrhythmia , Hypertension , Adverse Effects , Side Effects , Blood , Patient Safety , Skin And Soft Tissue Infection ,